Corpovael Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Corpovael stock have an average target of $8.50, which predicts a 17.24% increase from the current stock price of 7.25.

Price Target: $8.50 (+17.24%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$8.50	$8.50	$8.50	$8.50
Change	+17.24%	+17.24%	+17.24%	+17.24%

Analyst Ratings

The average analyst rating for Corpovael stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Oct '25	Jan '26	Feb '26	Apr '26	Jul '26	Oct '26
Strong Buy	2	1	1	0	1	1
Buy	0	0	0	0	0	0
Hold	0	1	1	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

5.69B

from 5.07B

12.32%

from 5.07B

Revenue Next Year

6.12B

from 5.69B

7.46%

from 5.69B

EPS This Year

1.36

from 1.36

EPS Next Year

1.38

from 1.36

1.47%

from 1.36

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.78B	3.73B	4.51B	4.49B	5.07B	5.69B
Revenue Growth	-15.74%	34.13%	20.91%	-0.41%	12.90%	12.32%
Gross Profit	684.78M	947.78M	1.22B	1.20B	1.20B	1.33B
Gross Margin	24.65%	25.43%	27.07%	26.68%	23.70%	23.40%
Operating Income	82.42M	376.80M	522.00M	427.67M	469.19M	588.00M
Net Income	-103.64M	258.96M	295.98M	232.03M	412.19M	397.00M
EPS	-	-	-	-	1.36	1.36
EPS Growth	-	-	-	-	81.33%	-
Forward PE	4.38	2.84	4.00	4.50	3.87	5.33
Free Cash Flow	-	-	-	-	-	418.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MXN.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	5.7B
Avg	5.7B
Low	5.6B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	13.4%
Avg	12.3%
Low	11.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.36
Avg	1.36
Low	1.36

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-